Literature DB >> 32947010

PINK1-mediated mitophagy protects against hepatic ischemia/reperfusion injury by restraining NLRP3 inflammasome activation.

Ying Xu1, Yinbing Tang2, Jiawei Lu2, Weiya Zhang2, Yan Zhu3, Shouliang Zhang2, Gui Ma2, Pengcheng Jiang4, Wenbo Zhang5.   

Abstract

Activation of nucleotide-binding domain leucine-rich repeat containing family pyrin domain containing 3 (NLRP3) inflammasome in Kupffer cells (KCs) contributes significantly to hepatic ischemia/reperfusion (I/R) injury, while the mechanism of how NLRP3 inflammasome is regulated remains less well defined. Recent evidence has showed that mitophagy acts as a central player for maintaining mitochondrial homeostatis through elimination of damaged mitochondria, leading to the prevention of hyperinflammation triggered by NLRP3 activation. In this study, we aimed at investigating the potential role of PTEN-induced kinase 1 (PINK1)-mediated mitophagy in hepatic I/R injury. C57BL/6 mice subjected to partial warm hepatic I/R or primary KCs exposed to anoxia/reoxygenation (A/R) was used as in vivo or in vitro model, respectively. Mitophagy was measured by protein levels of PINK1, Parkin, LC3B-II, TOMM20 and p62. NLRP3, caspase-1 and IL-1β at mRNA and/or protein levels were used as indicators of inflammasome activation. Our results demonstrated remarkable hepatic inflammation and NLRP3 inflammasome activation during hepatic I/R, along with increased PINK1-mediated mitophagy. Notably, overexpression of PINK1 in vivo attenuated hepatic I/R injury, ROS production, NLRP3 activation and hepatic inflammation. In parallel, A/R challenge in vitro also triggered NLRP3 activation in KCs accompanied by increase in mitophagy. Enhanced mitophagy mediated by PINK1 overexpression further inhibited NLRP3 activation and reversed the KC-mediated inflammatory injury to hepatocytes. Kinase-dead mutation of PINK1 completely abolished the above protective effects by PINK1. Blocking of mitophagy/autophagy by silencing of PINK1/Parkin, ATG5, NDP52 or OPTN showed the totally opposite effects, respectively. Treatment with different autophagic inhibitors also consistently reversed the PINK1-mediated effects, suggesting that an intact PINK1-mediated mitophagy signaling was crucial for ablation of NLRP3 signaling in the presence of A/R. Together, these results support a critical role of PINK1-mediated mitophagy in mitochondrial quality control for KC activation and function in hepatic I/R.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hepatic ischemia/reperfusion injury; Inflammasome; Mitophagy; NLRP3; PINK1

Mesh:

Substances:

Year:  2020        PMID: 32947010     DOI: 10.1016/j.freeradbiomed.2020.09.015

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  20 in total

1.  A20 attenuates pyroptosis and apoptosis in nucleus pulposus cells via promoting mitophagy and stabilizing mitochondrial dynamics.

Authors:  Xin Peng; Cong Zhang; Zhi-Min Zhou; Kun Wang; Jia-Wei Gao; Zhan-Yang Qian; Jun-Ping Bao; Hang-Yu Ji; V L F Cabral; Xiao-Tao Wu
Journal:  Inflamm Res       Date:  2022-04-15       Impact factor: 4.575

Review 2.  Targeting the Hepatic Microenvironment to Improve Ischemia/Reperfusion Injury: New Insights into the Immune and Metabolic Compartments.

Authors:  Fengqiang Gao; Xun Qiu; Kai Wang; Chuxiao Shao; Wenjian Jin; Zhen Zhang; Xiao Xu
Journal:  Aging Dis       Date:  2022-07-11       Impact factor: 9.968

3.  PINK1 overexpression prevents forskolin-induced tau hyperphosphorylation and oxidative stress in a rat model of Alzheimer's disease.

Authors:  Xiao-Juan Wang; Lin Qi; Ya-Fang Cheng; Xue-Fei Ji; Tian-Yan Chi; Peng Liu; Li-Bo Zou
Journal:  Acta Pharmacol Sin       Date:  2021-12-10       Impact factor: 7.169

4.  Lycopene alleviates hepatic ischemia reperfusion injury via the Nrf2/HO-1 pathway mediated NLRP3 inflammasome inhibition in Kupffer cells.

Authors:  Rong Xue; Jiannan Qiu; Song Wei; Mu Liu; Qi Wang; Peng Wang; Bowen Sha; Hao Wang; Yong Shi; Jinren Zhou; Jianhua Rao; Ling Lu
Journal:  Ann Transl Med       Date:  2021-04

5.  Rosiglitazone ameliorates acute hepatic injury via activating the Nrf2 signaling pathway and inhibiting activation of the NLRP3 inflammasome.

Authors:  Ling Ma; Ying Ma; Bin-Xi Ma; Ming Ma
Journal:  Exp Ther Med       Date:  2022-02-21       Impact factor: 2.447

Review 6.  New Insights Into the Role of Autophagy in Liver Surgery in the Setting of Metabolic Syndrome and Related Diseases.

Authors:  Ana Isabel Álvarez-Mercado; Carlos Rojano-Alfonso; Marc Micó-Carnero; Albert Caballeria-Casals; Carmen Peralta; Araní Casillas-Ramírez
Journal:  Front Cell Dev Biol       Date:  2021-06-01

Review 7.  Molecular Perspectives of Mitophagy in Myocardial Stress: Pathophysiology and Therapeutic Targets.

Authors:  Haizhe Ji; Dan Wu; O'Maley Kimberlee; Ruibing Li; Geng Qian
Journal:  Front Physiol       Date:  2021-06-30       Impact factor: 4.755

8.  Rapamycin inhibits LOC102553434-mediated pyroptosis to improve lung injury induced by limb ischemia-reperfusion.

Authors:  Dan Huang; Lie-Liang Zhang; Bin Zhou; Zhen-Zhong Luo; Jing Zhang; Bin Tang; Shu-Chun Yu
Journal:  3 Biotech       Date:  2021-06-16       Impact factor: 2.893

9.  A Single, Acute Astragaloside IV Therapy Protects Cardiomyocyte Through Attenuating Superoxide Anion-Mediated Accumulation of Autophagosomes in Myocardial Ischemia-Reperfusion Injury.

Authors:  Kai-Yu Huang; Yong-Wei Yu; Shuai Liu; Ying-Ying Zhou; Jin-Sheng Wang; Yang-Pei Peng; Kang-Ting Ji; Yang-Jing Xue
Journal:  Front Pharmacol       Date:  2021-07-19       Impact factor: 5.810

Review 10.  The Role of Mitochondria in Liver Ischemia-Reperfusion Injury: From Aspects of Mitochondrial Oxidative Stress, Mitochondrial Fission, Mitochondrial Membrane Permeable Transport Pore Formation, Mitophagy, and Mitochondria-Related Protective Measures.

Authors:  Haifeng Zhang; Qi Yan; Xuan Wang; Xin Chen; Ying Chen; Jian Du; Lijian Chen
Journal:  Oxid Med Cell Longev       Date:  2021-07-05       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.